Patent · US Active

Photodynamic therapy for use in treating cancer

US10661095B2 · kind B2 · utility

0Cited by
1References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 25, 2016
Grant dateMay 26, 2020
Priority date
Expiry dateAug 25, 2036

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61N5/022
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed is the use of copper cysteamine nanoparticles for use in photodynamic cancer therapy. The disclosed methods of treatment utilize microwave radiation as a means for activating the copper cysteamine photosensitizer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.